Computer-Aided Drug Design

joint with New Directions in Small Molecule Drug Discovery

Organizer(s): Michael K. Gilson, Catherine E. Peishoff and Jeff Blaney

Sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Summary of Meeting:

The purpose of this meeting is to stimulate progress in the methods of computer-aided drug design. This will be accomplished by bringing theory and practice into contact at a number of levels in order to highlight interesting and important practical problems waiting to be solved, and by deepening participants’ understanding of the science underlying these challenges.

Scholarship Deadline: December 21 2009

Discounted Abstract Deadline: December 21 2009

Abstract Deadline: January 20 2010

Discounted Registration Deadline: February 23 2010

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Abbott Laboratories

AstraZeneca Pharmaceuticals, L.P.

GlaxoSmithKline

Schering-Plough Research Institute

Schrödinger

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of General Medical Sciences (NIGMS)
Grant No. 1R13GM093403-01

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations